Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,033 | 18,633 | 18,682 | 42,952 | 25,706 |
| Marketable Securities | 201,267 | 229,007 | 247,000 | 236,145 | 129,840 |
| TOTAL | $226,075 | $250,233 | $268,592 | $282,569 | $158,432 |
| Non-Current Assets | |||||
| PPE Net | 5,904 | 4,882 | 5,223 | 5,168 | 4,947 |
| Other Non-Current Assets | 1,932 | 1,991 | 2,050 | 2,130 | 2,290 |
| TOTAL | $7,836 | $6,873 | $7,273 | $7,298 | $7,237 |
| Total Assets | $233,911 | $257,106 | $275,865 | $289,867 | $165,669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,922 | 1,556 | 1,275 | 1,461 | 1,272 |
| Accrued Expenses | 3,085 | 9,338 | 4,517 | 3,352 | 2,533 |
| TOTAL | $8,039 | $11,527 | $8,422 | $7,785 | $7,041 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 262 | 129 | N/A | 105 | N/A |
| Other Non-Current Liabilities | 112 | 117 | 123 | 128 | 133 |
| TOTAL | $9,292 | $9,430 | $9,479 | $9,397 | $9,316 |
| Total Liabilities | $17,331 | $20,957 | $17,901 | $17,182 | $16,357 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,145 | 7,144 | 7,124 | 7,122 | 5,229 |
| Common Shares | 71 | 71 | 71 | 71 | 52 |
| Retained earnings | -684,581 | -661,407 | -635,620 | -617,689 | -596,215 |
| Other shareholders' equity | 25 | 6 | -22 | 60 | 35 |
| TOTAL | $216,580 | $236,149 | $257,964 | $272,685 | $149,312 |
| Total Liabilities And Equity | $233,911 | $257,106 | $275,865 | $289,867 | $165,669 |